Global Therapeutics Receives CE Mark Approval For Advanced GTX® Bare Metal Coronary Stent System Designed For Optimal Clinical Performance |
Global Therapeutics Receives CE Mark Approval For Advanced GTX® Bare Metal Coronary Stent System Designed For Optimal Clinical PerformanceGlobal Therapeutics, cardiology unit of Cook Medical, has received CE Mark approval for a new cobalt chromium bare metal coronary stent that company executives believe will fill a demand for non-drug eluting coronary stents among interventional cardiologists, company announced today. The device, Global Therapeutics GTX® Coronary Stent System, is available immediately in the European Union and United Kingdom. " Ever since the issue of late-stage thrombosis associated with drug-eluting coronary stents ( DECS ) came to light recently, interventional cardiologists have been re-examining valuable role bare metal stents can play in treating coronary artery disease in many patients, " explained Joe Horn, president of Global Therapeutics. " Not only do our bare metal stents eliminate concerns associated with potential delayed reactions from DES in certain coronary patients, our bare metal cobalt chromium stent has advanced features designed to improve clinical performance of BMS in coronary arteries. The GTX stent has been engineered specifically to eliminate the technical challenges, such as recoil, stent balloon retention and stent spring-back, that have been associated with earlier cobalt chromium stent designs currently on the market. " In addition to these technical advantages, Horn added, GTX may offer a significant cost-savings. Bare metal versions of coronary stents historically cost about one-third as much as their drug-coated iterations, making bare metal stents a more cost-effective option in treating many coronary disease patients. " This device fills a real need at a time when health care systems around world are struggling to contain skyrocketing healthcare costs for heart disease, leading killer in the industrialised world, " Horn said. " Not every coronary patient truly needs a drug-eluting stent, and we feel GTX platform offers a significant advance in bare metal stent technology many cardiologists and hospitals will welcome both for its potential clinical benefits and for its cost-effectiveness. " Global Therapeutics also is developing a breakthrough drug-eluting stent ( DES ) technology using GTX platform and an improved application of antisense gene therapy-developed by its partner, AVI BioPharma, Inc. ( NASDAQ: AVII: http: //www. avibio. com ) of Corvallis, Oregon-to inhibit the proliferation of a gene known to induce restenosis process, Horn added. The clinical trial is expected to begin in third quarter of 2008 in Europe. About Cook Medical Cook Medical was one of first companies to help popularise interventional medicine, pioneering many of devices now commonly used worldwide to perform minimally invasive medical procedures. Today, the company integrates device design, biopharma, gene and cell therapy and biotech to enhance patient safety and improve clinical outcomes in the fields of aortic intervention; interventional cardiology; critical care medicine; gastroenterology; radiology, peripheral vascular, bone access and oncology; surgery and soft tissue repair; urology; and assisted reproductive technology, gynecology and high-risk obstetrics. Cook is a past winner of prestigious Medical Device Manufacturer of Year Award from Medical Device & Diagnostic Industry magazine. Cook Medical Healthcare recommendations for woman and man |
Modern medicine: Diazepam.uses of Diazepam Diazepam is used to treat episodes of increased seizures ( e. g. , acute repetitive seizures, breakthrough seizures ) in people who are already taking medications to control their seizures. Diazepam is only recommended for short-term treatment of seizure attacks. It's not for ongoing daily use to prevent seizures. Uncontrolled seizures can turn into serious ( possibly fatal ) seizures that do not stop ( status epilepticus ) . how to use of Diazepam Read the Patient/Caregiver Information Leaflet provided by your pharmacist before you use Diazepam and each time we get a refill. If we have questions, consult your doctor or pharmacist. side effects of Diazepam Drowsiness, dizziness, diarrhea, and unsteadiness may occur. If these persist or worsen, notify your doctor promptly. precautions of Diazepam Before using Diazepam, tell your doctor or pharmacist if we are allergic to it; or to other benzodiazepines ( e. g. , oxazepam, temazepam ) ; or if we have any other allergies. interactions of Diazepam Your healthcare professionals ( e. g. , doctor or pharmacist ) may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop or change dosage of any medicine before checking with them first. Where to buy cheap Diazepam |
FDA 101: Advisory Committees. FDA's Advisory Committees are critical to the agency's product review process. Find out the basics of putting special government employees with different perspectives on such scientific committees. Botulism Risk from Canned Green Beans. FDA is warning consumers about potentially contaminated canned cut green beans manufactured by New Era Canning Company, New Era, Mich. New Era is voluntarily recalling the green beans because they may be contaminated with Clostridium botulinum (C. botulinum), the bacterium that causes botulism. Prilosec and Nexium: No Increased Risk of Heart Problems Found. After a comprehensive, scientific review, FDA has determined that Prilosec (omeprazole) and Nexium (esomeprazole) are not likely to be associated with an increased risk of heart problems Facts About Crohn's Disease. On January 14, 2008, FDA approved Tysabri (natalizumab) for certain patients with moderate-to-severe Crohn's disease, a chronic inflammatory condition of the digestive tract. Here are facts about the symptoms and treatments for this condition. |
AHN - Amgen Drug Cuts Bone Loss In Prostate Cancer Patients. Biotech drug manufacturer Amgen Inc. is reporting that a new drug under testing has been shown to prevent bone loss in men with prostate cancer. Tue, 15 Jul 2008 00:25:03 GMT. AHN - Doctors Report More Young Athletes Require Elbow Surgery. Basketball injuries cause a large number of young athletes to suffer from elbow injuries. These injuries often require surgery, according to a study released during annual meetings of the American Orthopaedic Society for Sports Medicine. Tue, 15 Jul 2008 07:09:21 GMT. AHN - Study: TV An Environmental Hazard For Young Children. A new study by a University of Massachusetts psychologist found out that the mere presence of an open television set in the background may be an environmental hazard for young children. Tue, 15 Jul 2008 10:27:26 GMT. AHN - Rise Of Kidney Stone Ailments Linked With Global Warming. A University of Texas Southwestern Medical School study linked the rise in kidney stone ailments to global warming. Tue, 15 Jul 2008 10:30:47 GMT. AHN - Roche Halts HIV Treatment Research. Drug maker Roche Holding AG has announced it will stop ongoing experiments for HIV treatment medicines after it determined their products did not result in any improvements compared to other drugs currently available. Tue, 15 Jul 2008 19:37:54 GMT. |
Global Therapeutics Receives CE Mark Approval For Advanced GTX® Bare Metal Coronary Stent System Designed For Optimal Clinical Performance Modern medicine: Diazepam. Where to buy cheap Diazepam FDA 101: Advisory Committees. FDA's Advisory Committees are critical to the agency's product review process. Find out the basics of putting special government employees with different perspectives on such scientific committees. Healthcare recommendations for woman and man |